Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China to Step Up Inspection of Fish Farms in Crackdown on Illegal Use of Drugs, Chemicals (China)

This article was originally published in PharmAsia News

Executive Summary

China will inspect fish farms across the country to guard against the use of illegal drugs and chemicals, a move that was made as a team of U.S. health officials met with Chinese officials to discuss stepping up controls on two-way food and drug exports and increasing cooperation. Besides inspections, the new measures also include the blacklisting of violators and better education and training for producers. U.S. Treasury Secretary Henry Paulson, who ended two days of trade talks with Chinese leaders in Beijing, said his discussions touched on consumer product safety and food safety but he gave no details. China's lucrative but lightly regulated pharmaceutical industry has also been under stricter surveillance. The former head of China's State Food and Drug Administration was executed in June for taking bribes and gifts in exchange for approving substandard medications for the domestic market, including an antibiotic blamed in the deaths of at least 10 people. China's drug watchdog has suspended sales of two batches of a leukemia drug that was under investigation after users reported adverse reactions including leg pains and difficulty walking. Shanghai Pharmaceutical (Group) Co., China's biggest drug-maker and the parent company of the unit that made the methotrexate, has said it was investigating the problem. (Click here for more - May Require Free Registration

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel